Martin R Berk MD FACC FAHA FASE FHFSA
Echocardiography, Heart Failure & Transplantation, Non-Invasive Cardiology, Preventive Cardiology
Texas Health Heart and Vascular Group
Join to view full profile
8440 Walnut Hill lane, Suite 400Ste 400Dallas, TX 75231
Phone+1 214-369-3613
Fax+1 469-916-7696
Dr. Berk is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Martin Berk is a cardiologist based in Dallas, TX, specializing in echocardiography, heart failure and transplantation, non-invasive cardiology, and preventive cardiology. He completed his medical education and fellowship at the University of Kentucky College of Medicine. Dr. Berk has extensive experience in general cardiology, hypertension, coronary artery disease, valvular heart disease, and cardiac catheterization. His research includes notable publications such as the REDUCE HTN: REINFORCE trial and studies on the efficacy of dofetilide. He has been involved in clinical trials like the EXSCEL study, and his work has been recognized with various certifications and honors, including being named a Super Doctor and a Fellow of the American College of Cardiology.
Education & Training
University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 1986 - 1989
University of Kentucky College of MedicineResidency, Internal Medicine, 1986 - 1989
University of the WitwatersrandClass of 1977
Certifications & Licensure
TX State Medical License 1992 - 2027
GA State Medical License 1991 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Aprima PRM 2014, Aprima Medical Software, Inc., 2013, 2017
- CMS Meaningful Use Stage 1 Certification Aprima, Aprima Medical Software, Inc., 2013, 2017
- CMS Meaningful Use Stage 1 Certification Aprima EHR, Aprima Medical Software, Inc., 2012
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure
Publications & Presentations
PubMed
- 69 citationsThe REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of HypertensionMichael A. Weber, SM Ajay J. Kirtane Md, Matthew R. Weir, Jai Radhakrishnan, Tony Das
JACC. Cardiovascular Interventions. 2020-02-24 - 318 citationsEfficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic At...Steven N. Singh, Robert G. Zoble, Laurence Yellen, Michael A. Brodsky, Gregory K. Feld
Circulation. 2000-11-07 - 9 citationsLeft atrial function in congestive heart failure: assessment by transmitral and pulmonary vein DopplerGong-Yuan Xie, Martin R. Berk, Andrew J. Fiedler, Peter M. Sapin, Mikel D. Smith
International Journal of Cardiac Imaging. 1998-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
